Documents › 3a0160e9792366039c4c24908c2d7e1cb47c0353:1-73

NHTSA Report: Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users

POST board policyreference 2022-12 73 pages (file pages 1–73) original file
About this document
Layer
attachment: a document a meeting packet links to
Type as titled
publication (kind from doc_type)
File
3a0160e9792366039c4c24908c2d7e1cb47c0353 application/pdf
Cases
POST 2313715 · Jaime Bermudez (filed under case)

About: Jaime Bermudez (case)

Page 13 · file page 13 larger image
Image of page 13; its text is alongside
Text: OCR

Because of the large number of drivers, the study was able to reliably analyze drug prevalence by driver demographics and other factors. Among drivers, males and females showed differences in drug category positivity with males more likely to be positive for some categories of drugs (i.e., alcohol, cannabinoids, stimulants) and females more likely to be positive for others (i.e., sedatives, antidepressants, over-the-counter [OTC] drugs). There were also a variety of differences in drug prevalence by driver age group, time of day, and day of week that are potentially useful for informing countermeasure development depending on the target audience.

Discussion

The results included in this report represent a first high-level look at drug prevalence among a large sample of seriously or fatally injured roadway users. Future research can analyze the data collected by this study to explore many more topics of interest. The study also sets an example by which future similar research can be conducted at other sites across the country. The participating Level 1 trauma centers and MEs were able to enact the study protocols without issue, even during the COVID-19 public health emergency. Future similar research at these sites or others across the country could be of use for monitoring changes in drugged driving over time and could inform traffic safety stakeholders to better tailor impaired driving countermeasures for particular regions or types of road users.

This study's results can only be used to estimate the prevalence of drug positivity among the specific populations sampled and with full awareness of the study's design limitations. The study results should not be used to imply impairment, or increased risk associated with drug presence.

5

Keys: ← → or j k turn pages; / finds.